GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blum Holdings Inc (OTCPK:BLMH) » Definitions » Cyclically Adjusted PS Ratio

Blum Holdings (Blum Holdings) Cyclically Adjusted PS Ratio : 0.01 (As of Jun. 09, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Blum Holdings Cyclically Adjusted PS Ratio?

As of today (2024-06-09), Blum Holdings's current share price is $0.59. Blum Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2023 was $48.36. Blum Holdings's Cyclically Adjusted PS Ratio for today is 0.01.

The historical rank and industry rank for Blum Holdings's Cyclically Adjusted PS Ratio or its related term are showing as below:

BLMH' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.19   Max: 1.63
Current: 0.01

During the past years, Blum Holdings's highest Cyclically Adjusted PS Ratio was 1.63. The lowest was 0.01. And the median was 0.19.

BLMH's Cyclically Adjusted PS Ratio is ranked better than
99.87% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs BLMH: 0.01

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Blum Holdings's adjusted revenue per share data for the three months ended in Sep. 2023 was $0.891. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $48.36 for the trailing ten years ended in Sep. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Blum Holdings Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Blum Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blum Holdings Cyclically Adjusted PS Ratio Chart

Blum Holdings Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.30 0.31 0.57 0.03

Blum Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.03 0.04 0.04 0.04

Competitive Comparison of Blum Holdings's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Blum Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blum Holdings's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Blum Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Blum Holdings's Cyclically Adjusted PS Ratio falls into.



Blum Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Blum Holdings's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.59/48.36
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Blum Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, Blum Holdings's adjusted Revenue per Share data for the three months ended in Sep. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=0.891/129.8595*129.8595
=0.891

Current CPI (Sep. 2023) = 129.8595.

Blum Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201312 7.138 98.326 9.427
201403 5.385 99.695 7.014
201406 33.143 100.560 42.800
201409 10.868 100.428 14.053
201412 11.866 99.070 15.554
201503 5.569 99.621 7.259
201506 34.889 100.684 44.999
201509 12.012 100.392 15.538
201512 8.247 99.792 10.732
201603 7.101 100.470 9.178
201606 41.631 101.688 53.164
201609 29.574 101.861 37.703
201612 19.320 101.863 24.630
201703 18.053 102.862 22.791
201706 20.162 103.349 25.334
201709 21.085 104.136 26.293
201712 18.508 104.011 23.108
201803 13.315 105.290 16.422
201806 12.690 106.317 15.500
201809 4.561 106.507 5.561
201812 8.636 105.998 10.580
201903 2.182 107.251 2.642
201906 4.249 108.070 5.106
201909 4.943 108.329 5.925
201912 3.889 108.420 4.658
202003 2.682 108.902 3.198
202006 1.454 108.767 1.736
202009 1.476 109.815 1.745
202012 -1.744 109.897 -2.061
202103 0.865 111.754 1.005
202106 1.109 114.631 1.256
202109 4.381 115.734 4.916
202112 3.094 117.630 3.416
202203 3.283 121.301 3.515
202206 2.743 125.017 2.849
202209 1.676 125.227 1.738
202212 1.292 125.222 1.340
202303 1.047 127.348 1.068
202306 1.053 128.729 1.062
202309 0.891 129.860 0.891

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Blum Holdings  (OTCPK:BLMH) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Blum Holdings Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Blum Holdings's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Blum Holdings (Blum Holdings) Business Description

Traded in Other Exchanges
N/A
Address
3242 South Halladay Street, Suite 202, Santa Ana, CA, USA, 92705
Blum Holdings Inc formerly Unrivaled Brands Inc is a vertically integrated cannabis multi-state operator having a cannabis brand spanning consumer products, cultivation, distribution, and retail. Its brands include Korova, Sticks, and Cabana, among others. It operates leading dispensaries throughout the state as well as several leading company-owned brands including Korova, known for its high potency products across multiple product categories.
Executives
Patty Chan officer: CHIEF FINANCIAL OFFICER 11516 DOWNEY AVE, DOWNEY CA 90241
Oren Schauble officer: President 3242 S HALLADAY ST., SUITE 202, SANTA ANA CA 92705
Dallas Imbimbo director 1800 NEWPORT CIRCLE, SANTA ANA CA 92705
Eric Baum director 866 BERKSHIRE DRIVE, WESTBURY NY 11590
Tiffany N. Davis director 11852 MANHATTAN CT., RANCHO CUCAMONGA CA 91730
Michael Nahass director 2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Derek Peterson director, officer: President and CEO 2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Alan David Gladstone other: Former Director of Issuer P.O BOX 9699, NEWPORT BEACH CA 92658
Uri Kenig officer: Chief Operating Officer 2040 MAIN ST., SUITE 225, IRVINE CA 92614
Ira E. Ritter director C/O RITTER PHARMACEUTICALS INC., 1801 CENTURY PARK EAST, SUITE 1820, LOS ANGELES CA 90096
Nicholas Kovacevich director 2618 SAN MIGUEL DRIVE, #480, NEWPORT BEACH CA 92660
Knuettel Ii Francis director 205 NEWBURY ST, SUITE 204, FRAMINGHAM MA 01701
Jeffrey Robert Batliner officer: Chief Financial Officer 2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Megan Jimenez officer: Chief Financial Officer 2040 MAIN ST., SUITE 225, IRVINE CA 92614
Matthew Morgan director, officer: Chief Executive Officer 2040 MAIN STREET, SUITE 225, IRVINE CA 92614